Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination
Crossref DOI link: https://doi.org/10.1007/s00262-015-1766-5
Published Online: 2015-10-26
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hansen, Gaute Lund
Gaudernack, Gustav
Brunsvig, Paal Fredrik
Cvancarova, Milada
Kyte, Jon Amund
Funding for this research was provided by:
Universitetet i Oslo (NO)
Helse Sør-Øst RHF (NO)
Text and Data Mining valid from 2015-10-26